SPOTLIGHT: Sciele readies six meds for market

by admin |

Sciele Pharma expects to launch six new products in 2008, executives announced, including a new formulation of its blood pressure drug Sular and two forms of the Prandin drug for Type II diabetes, plus at least two meds awaiting FDA approval. Release

Suggested Articles

AstraZeneca
Marketing

AZ's Calquence steps up to challenge Imbruvica with big CLL nod

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

by Carly Helfand, by Angus Liu
jnj
Pharma

J&J's Risperdal caseload explodes with Pennsylvania ruling

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

by Eric Sagonowsky
Black-and-white image of a thumbs-up hand and a thumbs-down hand in front of a blank wall.
Marketing

Which asthma biologic is the most popular of them all?

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.

by Angus Liu